Ductal and Acinar Adenocarcinoma of Prostate Morphological and Immunohistochemical Characterization
Objectives: We sought to characterize the ductal and acinar subtype of prostate adenocarcinoma using hematoxylin and eosin (H&E) staining and an immunohistochemical antibody cocktail. We also investigated the clinical features, prostate-specific antigen (PSA) levels, and biological aggressivenes...
Saved in:
Published in: | Oman medical journal Vol. 30; no. 3; pp. 162 - 166 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Muscat - Oman
Oman Medical Specialty Board
01-05-2015
OMJ |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives: We sought to characterize the ductal and acinar subtype of prostate
adenocarcinoma using hematoxylin and eosin (H&E) staining and an immunohistochemical
antibody cocktail. We also investigated the clinical features, prostate-specific antigen (PSA)
levels, and biological aggressiveness of these tumors. Methods: We utilized tumor bearing
prostate biopsies, obtained between 2010 and 2014 from Dow Diagnostic Research and
Reference Laboratory, to identify cases of prostatic ductal and acinar adenocarcinoma using
routine H&E and immunohistochemical staining. The immunohistochemical antibody
cocktail 34βE12/p63/AMACR was used for staining. The association of clinicopathological
variables including patient’s age at diagnosis, Gleason score, and PSA levels before surgery
was retrospectively analyzed. Results: A total of 10 ductal and 140 non-ductal cases were
identified. Ductal cases were predominantly high grade with advanced histopathological
features (90%; p=0.030). Marked elevation in PSA level was also reported in most cases.
No other significant statistical difference was observed. Conclusions: Pathological and
immunohistochemical examination could be used to characterize ductal and acinar
adenocarcinoma of the prostate. Ductal adenocarcinoma of the prostate is a rare subtype of
prostate carcinoma and is be more likely to present with advanced grade cancer suggesting
that timely detection of the disease is vital. |
---|---|
Bibliography: | Oman Medical Journal, Vol. 30, No. 3, May 2015: 162-166 OMJ.jpg ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1999-768X 2070-5204 |
DOI: | 10.5001/omj.2015.36 |